CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- DEF 14A Proxy Proxy Statement
- 4 Grant or award Director acquired 21,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale CFO and CBO sold 3,678 shares at $4.55 ($16,740)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Executive or director change
- 4 Option exercise Director acquired 7,500 shares (option exercise)
- 4 Open-market buy Director bought 10,000 shares at $4.42 ($44,200)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO and CBO acquired 72,000 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 79,200 shares (grant or award)
- 4 Open-market sale CFO and CBO sold 6,583 shares at $6.59 ($43,371)
- 4 Open-market sale Chief Operating Officer sold 7,886 shares at $6.59 ($51,957)
- 4 Open-market sale President and Chief Executive sold 19,109 shares at $6.59 ($125,884)
Page 6 of 25 · 496 filings